William Todd Cade1,2, Kathryn L Bohnert1, Linda R Peterson2, Bruce W Patterson2, Adam J Bittel1, Adewole L Okunade2, Lisa de Las Fuentes2, Karen Steger-May3, Adil Bashir4,5, George G Schweitzer2, Shaji K Chacko6, Ronald J Wanders7, Christina A Pacak8, Barry J Byrne8, Dominic N Reeds2. 1. Program in Physical Therapy, Washington University School of Medicine, St. Louis, Missouri. 2. Department of Medicine, Washington University School of Medicine, St. Louis, Missouri. 3. Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri. 4. Department of Radiology, Washington University School of Medicine, St. Louis, Missouri. 5. Department of Electrical and Computer Engineering, Auburn University, Auburn, Alabama. 6. Department of Pediatrics, Baylor College of Medicine, Houston, Texas. 7. Department of Pediatrics, University of Amsterdam, Amsterdam, The Netherlands. 8. Department of Pediatrics, University of Florida, Gainesville, Florida.
Abstract
Barth syndrome (BTHS) is a rare X-linked condition resulting in abnormal mitochondria, cardioskeletal myopathy, and growth delay; however, the effects of BTHS on substrate metabolism regulation and their relationships with tissue function in humans are unknown. We sought to characterize glucose and fat metabolism during rest, submaximal exercise, and postexercise rest in children, adolescents, and young adults with BTHS and unaffected controls and examine their relationships with cardioskeletal energetics and function. Children/adolescents and young adults with BTHS (n = 29) and children/adolescent and young adult control participants (n = 28, total n = 57) underwent an infusion of 6'6'H2 glucose and U-13 C palmitate and indirect calorimetry during rest, 30-minutes of moderate exercise (50% V ˙ O 2 peak ), and recovery. Cardiac function, cardioskeletal mitochondrial energetics, and exercise capacity were examined via echocardiography, 31 P magnetic resonance spectroscopy, and peak exercise testing, respectively. The glucose turnover rate was significantly higher in individuals with BTHS during rest (33.2 ± 9.8 vs 27.2 ± 8.1 μmol/kgFFM/min, P < .01) and exercise (34.7 ± 11.2 vs 29.5 ± 8.8 μmol/kgFFM/min, P < .05) and tended to be higher postexercise (33.7 ± 10.2 vs 28.8 ± 8.0 μmol/kgFFM/min, P < .06) compared to controls. Increases in total fat (-3.9 ± 7.5 vs 10.5 ± 8.4 μmol/kgFFM/min, P < .0001) and plasma fatty acid oxidation rates (0.0 ± 1.8 vs 5.1 ± 3.9 μmol/kgFFM/min, P < .0001) from rest to exercise were severely blunted in BTHS compared to controls. Conclusion: An inability to upregulate fat metabolism during moderate intensity exercise appears to be partially compensated by elevations in glucose metabolism. Derangements in fat and glucose metabolism are characteristic of the pathophysiology of BTHS. A severely blunted ability to upregulate fat metabolism during a modest level of physical activity is a defining pathophysiologic characteristic in children, adolescents, and young adults with BTHS.
Barth syndrome (BTHS) is a rare X-linked condition resulting in abnormal mitochondria, cardioskeletal myopathy, and growth delay; however, the effects of BTHS on substrate metabolism regulation and their relationships with tissue function in humans are unknown. We sought to characterize glucose and fat metabolism during rest, submaximal exercise, and postexercise rest in children, adolescents, and young adults with BTHS and unaffected controls and examine their relationships with cardioskeletal energetics and function. Children/adolescents and young adults with BTHS (n = 29) and children/adolescent and young adult control participants (n = 28, total n = 57) underwent an infusion of 6'6'H2 glucose and U-13 C palmitate and indirect calorimetry during rest, 30-minutes of moderate exercise (50% V ˙ O 2 peak ), and recovery. Cardiac function, cardioskeletal mitochondrial energetics, and exercise capacity were examined via echocardiography, 31 P magnetic resonance spectroscopy, and peak exercise testing, respectively. The glucose turnover rate was significantly higher in individuals with BTHS during rest (33.2 ± 9.8 vs 27.2 ± 8.1 μmol/kgFFM/min, P < .01) and exercise (34.7 ± 11.2 vs 29.5 ± 8.8 μmol/kgFFM/min, P < .05) and tended to be higher postexercise (33.7 ± 10.2 vs 28.8 ± 8.0 μmol/kgFFM/min, P < .06) compared to controls. Increases in total fat (-3.9 ± 7.5 vs 10.5 ± 8.4 μmol/kgFFM/min, P < .0001) and plasma fatty acid oxidation rates (0.0 ± 1.8 vs 5.1 ± 3.9 μmol/kgFFM/min, P < .0001) from rest to exercise were severely blunted in BTHS compared to controls. Conclusion: An inability to upregulate fat metabolism during moderate intensity exercise appears to be partially compensated by elevations in glucose metabolism. Derangements in fat and glucose metabolism are characteristic of the pathophysiology of BTHS. A severely blunted ability to upregulate fat metabolism during a modest level of physical activity is a defining pathophysiologic characteristic in children, adolescents, and young adults with BTHS.
Authors: D N Reeds; K E Yarasheski; L Fontana; W T Cade; E Laciny; A DeMoss; B W Patterson; W G Powderly; S Klein Journal: Am J Physiol Endocrinol Metab Date: 2005-08-23 Impact factor: 4.310
Authors: Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart Journal: J Am Soc Echocardiogr Date: 2005-12 Impact factor: 5.251
Authors: George L Bakris; Vivian Fonseca; Richard E Katholi; Janet B McGill; Franz H Messerli; Robert A Phillips; Philip Raskin; Jackson T Wright; Rosemary Oakes; Mary Ann Lukas; Karen M Anderson; David S H Bell Journal: JAMA Date: 2004-11-10 Impact factor: 56.272
Authors: Luc J C van Loon; Rene Koopman; Jos H C H Stegen; Anton J M Wagenmakers; Hans A Keizer; Wim H M Saris Journal: J Physiol Date: 2003-09-26 Impact factor: 5.182
Authors: Mette C ØRngreen; Mette G Nørgaard; Massimo Sacchetti; Baziel G M van Engelen; John Vissing Journal: Ann Neurol Date: 2004-08 Impact factor: 10.422
Authors: Peter G Barth; Fredoen Valianpour; Valerie M Bowen; Jan Lam; Marinus Duran; Frédéric M Vaz; Ronald J A Wanders Journal: Am J Med Genet A Date: 2004-05-01 Impact factor: 2.802
Authors: Catherine H Le; Lindsay G Benage; Kalyn S Specht; Lance C Li Puma; Christopher M Mulligan; Adam L Heuberger; Jessica E Prenni; Steven M Claypool; Kathryn C Chatfield; Genevieve C Sparagna; Adam J Chicco Journal: J Biol Chem Date: 2020-07-14 Impact factor: 5.157
Authors: W Todd Cade; Kathryn L Bohnert; Adam J Bittel; Shaji J Chacko; Bruce W Patterson; Christina A Pacak; Barry J Byrne; Hilary J Vernon; Dominic N Reeds Journal: Mol Genet Metab Rep Date: 2020-11-04
Authors: Mindong Ren; Paighton C Miller; Michael Schlame; Colin K L Phoon Journal: Am J Physiol Heart Circ Physiol Date: 2019-10-11 Impact factor: 4.733
Authors: William Todd Cade; Richard Laforest; Kathryn L Bohnert; Dominic N Reeds; Adam J Bittel; Lisa de Las Fuentes; Adil Bashir; Pamela K Woodard; Christina A Pacak; Barry J Byrne; Robert J Gropler; Linda R Peterson Journal: J Nucl Cardiol Date: 2019-11-08 Impact factor: 3.872
Authors: Silveli Suzuki-Hatano; Mughil Sriramvenugopal; Manash Ramanathan; Meghan Soustek; Barry J Byrne; W Todd Cade; Peter B Kang; Christina A Pacak Journal: Int J Mol Sci Date: 2019-07-11 Impact factor: 5.923
Authors: Kathryn L Bohnert; Grace Ditzenberger; Adam J Bittel; Lisa de Las Fuentes; Manuela Corti; Christina A Pacak; Carolyn Taylor; Barry J Byrne; Dominic N Reeds; W Todd Cade Journal: JIMD Rep Date: 2021-08-09
Authors: Erica M Fatica; Gina A DeLeonibus; Alisha House; Jillian V Kodger; Ryan W Pearce; Rohan R Shah; Liraz Levi; Yana Sandlers Journal: Metabolites Date: 2019-12-17
Authors: Joel James; Mathews Valuparampil Varghese; Mikhail Vasilyev; Paul R Langlais; Stevan P Tofovic; Olga Rafikova; Ruslan Rafikov Journal: Int J Mol Sci Date: 2020-08-08 Impact factor: 5.923